loading..

NEWS

NEWS

More

11

2026.07

Setting Off from pkusz Tang Fu: Once You Cross the Mountain, the View Expands

Tang Fu is a 2020 Ph.D. candidate at the School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, under the supervision of Professor Yang Zhen. His research focuses on the total synthesis of natural products. During his doctoral studies, he published papers in the top organic chemistry journal Journal of the American Chemical Society (IF = 15.6) and Tetrahedron ...

11

2026.07

Tian Yu: Eyes on the Stars for Patients, Feet on the Ground in Delivery

The results of Peking University’s 2026 Outstanding Doctoral Dissertation Awards have recently been announced. Dr. Tian Yu, a doctoral graduate supervised by Associate Professor Andrew S. Lee at the School of Chemical Biology and Biotechnology, received this honor for his dissertation titled “Non-viral Delivery of FullLength Dystrophin mRNA Targeted to Skeletal Muscle for DMD Therapy.”Peking...

29

2026.06

School of Chemical Biology and Biotechnology, The 4th Doctoral Academic Conference on Disease Target Research and Novel Drug Discovery Successfully Held

To enhance the scientific research literacy of all students, promote academic exchange, and deepen cross-laboratory collaboration, and with the support of Peking University's "Graduate Education Innovation Program," the 4th Doctoral Academic Conference on Disease Target Research and Novel Drug Discovery was officially opened on the morning of June 25, 2026, in the Lecture Hall of Building D,Pek...

24

2026.04

Academic Exchange Highlight | Professor Zhong Guofu from Ningbo University of Technology Visits SCBB for Academic Exchange

To deepen academic collaboration and broaden scientific research horizons, Professor Guofu Zhong from the Department of Science at the Eastern Institute of Technology (EIT), Ningbo, visited the school on April 23, 2026,viathe invitation of Professor Hongbin Zhai. During his visit, Professor Zhong delivered an insightful academic lecture titledFrom Antibody Catalysis to Organocatalysis and the C...

31

2026.03

Building Dreams in the Bay Area, Advancing the Quest for Truth — Co-Hosting the 2026 Greater Bay Area Bioindustry Summit: Advancing Cell and Gene Therapy at the 4th Xunzhen Industry Forum

From March 28 to 29, 2026, the2026 Greater Bay Area Biopharmaceutical Industry Development Seminarand the4th Xunzhen Cell and Gene Industry Development Forumwere grandly convened in Shenzhen. Focused uponthe themeBuilding Dreams in the Bay Area, Pursuing Truth and Scientific Knowledge,the two-day event was guided by the Shenzhen Municipal Biopharmaceutical and Medical Device Industry Office. It...

NOTICE

NOTICE

More

RESEARCH

RESEARCH

More

AI4S (AI for Science) - AI in Materials Applications: The Yuqian Chen Team Makes Significant Progress in the Research of Efficient Equivariant Model-Based Machine Learning Interatomic Potentials

Recently, the research team led by Yuqian Chen at the School of Chemical Biology and Biotechnology and the School of Scientific Intelligence at Peking University, in collaboration with the National University of Singapore, developed a machine learning interatomic potential model named E2GNN based on an efficient equivariant model. Unlike traditional equivariant models that rely on complex high-order tensor representations,E2GNN encodes equivariant features using a concise scalar-vector representation and incorporates a global message-passing mechanism. This approach enables a more accurate description of long-range atomic interactions, achieving efficient and physically reasonable potential energy predictions. The related findings were published in the prestigious AI4M (AI for Materials) journalnpj Computational Materials (a top-tier journal in the Chinese Academy

Recently, the research team led by Yuqian Chen at the School of Chemical Biology and Biotechnology and the School of Scientific Intelligence at Peking University, in collaboration with the National University of Singapore, developed a machine learning interatomic potential model named E2GNN based on an efficient equivariant model. Unlike traditional equivariant models that rely on complex high-order tensor representations,E2GNN encodes equivariant features using a concise scalar-vector representation and incorporates a global message-passing mechanism. This approach enables a more accurate description of long-range atomic interactions, achieving efficient and physically reasonable potential energy predictions. The related findings were published in the prestigious AI4M (AI for Materials) journalnpj Computational Materials (a top-tier journal in the Chinese Academy

More+

Bo Zhang Lab has elucidated the mechanism of action of atypical cadherin FAT2, which is associated with ataxia/autism.

​Motor ability, as a core product of animal evolution, is an adaptive survival skill essential for sustaining life. The integrity of the motor system directly determines an individual’s success in food chain competition, predator avoidance, and access to reproductive opportunities. In vertebrates, the cadherin FAT family comprises a group of single-pass transmembrane cell adhesion molecules, consisting of four members: FAT1–4. Each FAT molecule possesses over 30 extracellular cadherin repeat domains along with related functional domains. Clinical studies have shown that mutations in the FAT2 gene are associated with motor coordination disorders and autism. Due to the large molecular weight and complex structure of these proteins, research on their functional mechanisms has long been hindered. Therefore, elucidating the molecular mechanism by which FAT2 regulates motor behavior provides a critical breakthrough for understanding the pathogenesis of motor disorders.

​Motor ability, as a core product of animal evolution, is an adaptive survival skill essential for sustaining life. The integrity of the motor system directly determines an individual’s success in food chain competition, predator avoidance, and access to reproductive opportunities. In vertebrates, the cadherin FAT family comprises a group of single-pass transmembrane cell adhesion molecules, consisting of four members: FAT1–4. Each FAT molecule possesses over 30 extracellular cadherin repeat domains along with related functional domains. Clinical studies have shown that mutations in the FAT2 gene are associated with motor coordination disorders and autism. Due to the large molecular weight and complex structure of these proteins, research on their functional mechanisms has long been hindered. Therefore, elucidating the molecular mechanism by which FAT2 regulates motor behavior provides a critical breakthrough for understanding the pathogenesis of motor disorders.

More+

The team of Zhen Yang/Zhongchao Zhang from Peking University published a paper in JACS: The First Asymmetric Total Synthesis of the Meroterpenoid Natural Product Janthinoid A

DMOA (3,5-Dimethylorsellinic Acid)-derived meroterpenoid natural products.Nowadays, over 200 compounds of this class have been reported, characterized by their structural complexity, large quantity, diverse oxidation states, and significant biological activities. Current synthetic efforts for this class of natural products have mainly targeted compounds like simplicissin, berkeleyone A, and and...

DMOA (3,5-Dimethylorsellinic Acid)-derived meroterpenoid natural products.Nowadays, over 200 compounds of this class have been reported, characterized by their structural complexity, large quantity, diverse oxidation states, and significant biological activities. Current synthetic efforts for this class of natural products have mainly targeted compounds like simplicissin, berkeleyone A, and and...

More+

Faculty

TEACHER

More
1

Dr.Hailin Peng

2000.9–2005.7: College of Chemistry and Molecular Engineering, Peking University, Ph.D 1996.9–2000.7: Department of Chemistry, Jilin University, Bachelor
2

Jinjun Gao, PhD

2014–2019: Ph.D in Integrated Life Sciences (Chemistry), Peking University2008–2014: Bachelor & Master in Life Sciences (Combined Program), Northeast Agricultural Universit
3

Dr.Yangbin Liu

2011-2016 doctor at Sichuan University2007-2011 Bachelor at Sichuan Universit
4

Dr.Yun Ge

2013–2018: Ph.D in Chemistry (Chemical Biology), Peking University2009–2013: Bachelor of Science in Chemistry, Xiamen Universit
5

Dr.Hao Huang

2006–2011: Ph.D in Biochemistry, University of Calgary, Canada1999–2002: Master in Analytical Chemistry, Tsinghua University1995–1999: Bachelor in Biology, Sichuan Universit
6

Dr.Yanlong Jiang

2012.09–2018.06: Ph.D. in Organic Chemistry, College of Chemistry, Peking University 2008.09–2012.07: Bachelor of Science, College of Chemistry, Peking University
7

Dr.Zigang Li

2004–2008: Ph.D in Chemistry, Department of Chemistry, University of Chicago 2001–2004: Master in Chemistry, Department of Chemistry, Tulane University 1996–2001: Bachelor in Neuroscience and Biophysics, University of Science and Technology of China
8

Dr.Tao Peng

2004–2009: Ph.D. in Science, The University of Hong Kong 2000–2004: Bachelor of Science, Peking University
9

Dr.Yundong Wu

1986 Doctorate in theoretical organic chemistry, University of Pittsburgh 1981 Bachelor of physical chemistry, Lanzhou University
10

Dr.Tao Ye

1989-1993 Queen's University, doctor 1983-1986 East China University of science and technology, master 1979-1983 East China University of science and technology, bachelor
11

Dr.Zhen Yang

1989-1992 Ph.D., Chemistry, The Chinese University of Hong Kong, with Professor Henry N. C. Wong 1983-1986 M.S., Pharmaceutical Chemistry, Shenyang College of Pharmacy, with Professor Qihuai Chen 1978-1982 B.A., Pharmaceutical Chemistry, Shenyang College of Pharmacy
12

Dr.Hongbin Zhai

1989-1995 Ph.D., organic chemistry, Ohio State University, Columbus, Ohio, USA 1985-1988 master, pharmacognosy / analytical chemistry, Peking Union Medical College, Beijing 1981-1985 bachelor, radiochemistry / Applied Chemistry, Peking University, Beijing
13

Dr.Zhengying Pan

1994-1999 Ph.D. Columbia University, New York 1989-1994 Bachelor, Peking University, Beijing
14

Andrew Stephen LEE

Andrew Lee MD PhD is an Associate Professor at Peking University Shenzhen Graduate School and is the Deputy Director of the SMART Hong Kong – Macau – Guangdong Greater Bay Area (GBA) International Clinical Trial Center. He also holds a joint appointment in the Institute of Cancer Research, Shenzhen Bay Laboratory. Andrew received his B.S. from Yale University, and his MD and PhD degrees from ...
15

Dr.Yu Cao

2007-2013 MD Anderson Cancer Research Center (Supervisor: Michael g. Rosenblum), postdoctoral2001-2007 Nankai University (Tutor: Baigang), doctor of Science1996-2000 Liaoning University, Bachelor of Scienc
16

Dr.Bo Zhang

2005.09-2011.07 Doctor, Peking University 2001.09-2005.07 Bachelor, Minzu University of China
17

Dr.Xian Jiang

2009-2014 Beijing Institute of life sciences, Tsinghua University; doctor2005-2009 Beijing Normal University; bachelo
18

Dr.Yandong Yin

2008.09-2013.07 doctor, School of chemistry and molecular engineering, Peking University 2004.09-2008.07 bachelor, chemistry and molecular engineering, Peking University
19

Dr.Lei Zhang

​2009-2016 PhD, Institute of molecular medicine, Peking University 2005-2009 Bachelor,College of Life and Environmental Sciences, Minzu University of China
20

Dr.Junmin Quan

2000-2004 Hong Kong University of science and technology, doctor 1997-2000 Sun Yat sen University, master 1993-1997 Peking University, Bachelor
1

Jinjun Gao, PhD
2

Dr.Yangbin Liu
3

Dr.Yun Ge
4

Dr.Hao Huang
5

Dr.Yanlong Jiang
6

Dr.Zigang Li
7

Dr.Tao Peng
8

Dr.Yundong Wu
9

Dr.Tao Ye
10

Dr.Zhen Yang
11

Dr.Hongbin Zhai
12

Dr.Zhengying Pan
13

Andrew Stephen LEE
14

Dr.Yu Cao
15

Dr.Bo Zhang
16

Dr.Xian Jiang
17

Dr.Yandong Yin
18

Dr.Lei Zhang
19

Dr.Junmin Quan
0

Dr.Hailin Peng

Contact Us

Contact Person: Ms. Lu

Tel: +86-755-2603-3049

Fax: +86-755-2603-3174

EMAIL: luyanan@pku.edu.cn

Address: Peking University Shenzhen Graduate School Building F 203, Xili University Town, Nanshan District, Shenzhen (518055)

Copyright © School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School     ICP License No.: 粤ICP备12081285号

Public Network Security License No.: 44030502008554        Technical Support: its@pkusz.edu.cn